C. Zoccali Et Al. , "Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges," NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.37, pp.14-23, 2022
Zoccali, C. Et Al. 2022. Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges. NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.37 , 14-23.
Zoccali, C., Ortiz, A., Blumbyte, I. A., Rudolf, S., Beck-Sickinger, A. G., Malyszko, J., ... Spasovski, G.(2022). Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges. NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.37, 14-23.
Zoccali, Carmine Et Al. "Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges," NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.37, 14-23, 2022
Zoccali, Carmine Et Al. "Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges." NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.37, pp.14-23, 2022
Zoccali, C. Et Al. (2022) . "Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges." NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.37, pp.14-23.
@article{article, author={Carmine Zoccali Et Al. }, title={Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges}, journal={NEPHROLOGY DIALYSIS TRANSPLANTATION}, year=2022, pages={14-23} }